The burden of anti-desmoglein-2 antibodies correlated positively with the number of VE beats and were present in patients without an identified ARVC genetic mutation in the human cohort studied. The gene discussed is DSG2; the disease is arrhythmogenic right ventricular cardiomyopathy.